Who is sponsoring NCT03359629?

NCT03359629 is sponsored by Tirat Carmel Mental Health Center.

What drugs are being tested in NCT03359629?

Interventions in NCT03359629: Spectrophon Glucometry Monitor, YSI 2300 Stat Plus.

What condition does NCT03359629 study?

NCT03359629 studies Glucose Metabolism Disorders, Diabetes Mellitus.

Is NCT03359629 still recruiting?

NCT03359629 is currently completed. Last updated 7 March 2019.

Are results published for NCT03359629?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-03-07 · How we verify

NCT03359629

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Spectrophon LTD Glucometry Monitor Accuracy

Completed Results posted Last updated 7 March 2019

What this trial tests

trial testing Spectrophon Glucometry Monitor in Glucose Metabolism Disorders in 210 participants. Completed in 16 October 2017.

Timeline

27 September 2017

Primary endpoint
15 October 2017

16 October 2017

Quick facts

Lead sponsor	Tirat Carmel Mental Health Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	210
Start date	27 September 2017
Primary completion	15 October 2017
Estimated completion	16 October 2017
Sites	1 location across Israel

Drugs / interventions tested

Spectrophon Glucometry Monitor
YSI 2300 Stat Plus

Conditions studied

Glucose Metabolism Disorders — all drugs for Glucose Metabolism Disorders →
Diabetes Mellitus — all drugs for Diabetes Mellitus →

Sponsor

Tirat Carmel Mental Health Center — full company profile →

Who can join

Adults 18 to 75, any sex, with Glucose Metabolism Disorders or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Percentage of Measurements With < 15% Error Primary · 1-3 hours

Difference in measurements of blood glucose level obtained using Spectrophon glucometry monitor and commercially available glucose analyser YSI 2300

Algorithm 1.7

Group	Value	95% CI
Blood Collection (Healthy Individuals)	95.25
Blood Collection (Diabetic Patients)	100

Algorithm 1.6

Group	Value	95% CI
Blood Collection (Healthy Individuals)	94.5
Blood Collection (Diabetic Patients)	100

Sponsor's own description

Diabetes mellitus (or diabetes) is a chronic, metabolic disease characterized by elevated levels of blood glucose. Patients with diabetes need to monitor their blood glucose level several times a day to control their medical state. Modern biosensors have become a promising solution for non-invasive blood glucose measurements. This study aims to validate the efficacy and the accuracy of Glucometry Monitor (NIGM) developed by Spectrophon LTD incorporated in smart watches. Method Participants will use Spectrophon biosensors to non-invasively estimate the level of glucose in blood. Blood will also be collected and the glucose level will be checked with commercially available blood glucose analyzers . All sets of data will be compared to estimate the accuracy of measurements of Spectrophon NIGM

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Glucose Metabolism Disorders

Currently open trials in the same condition.

NCT06763562 — Food Orders on Blood Glucose and Fuel Use At Rest · NA · recruiting
NCT06674980 — Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DF · NA · recruiting
NCT06051318 — Relationship Between Individual Effect of Diet on Postprandial Glycemia and Gut Microbiome Profile in Healthy Subjects · NA · recruiting
NCT06358716 — Glycaemic Index Determination in Oral Nutrition Supplements · NA · recruiting
NCT06878781 — Postprandial Metabolome and Metabolic Flexibility · NA · recruiting

Other Tirat Carmel Mental Health Center trials

Trials by the same sponsor.

NCT04186507 — Indirect Evaluation of Lithium Level in Blood Using Non-invasive Sweat Biosensors · unknown
NCT03229109 — Analysis of Sweat Secretion and Body Dehydration Monitoring · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03359629 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tirat Carmel Mental Health Center
Last refreshed: 7 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03359629.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing